Primary sclerosing cholangitis

Last updated: February 22, 2023

Primary sclerosing cholangitis

Watch later

Watch later

Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)
DNA cloning
ELISA (Enzyme-linked immunosorbent assay)
Fluorescence in situ hybridization
Gel electrophoresis and genetic testing
Karyotyping
Polymerase chain reaction (PCR) and reverse-transcriptase PCR (RT-PCR)
Acid-base map and compensatory mechanisms
Buffering and Henderson-Hasselbalch equation
Physiologic pH and buffers
The role of the kidney in acid-base balance
Metabolic acidosis
Plasma anion gap
Respiratory acidosis
Metabolic alkalosis
Respiratory alkalosis
Anaphylaxis
Food allergy
Type I hypersensitivity
Autoimmune hemolytic anemia
Goodpasture syndrome
Graves disease
Hemolytic disease of the newborn
Myasthenia gravis
Pemphigus vulgaris
Rheumatic heart disease
Type II hypersensitivity
Poststreptococcal glomerulonephritis
Serum sickness
Systemic lupus erythematosus
Type III hypersensitivity
Graft-versus-host disease
Type IV hypersensitivity
Isolated primary immunoglobulin M deficiency
Selective immunoglobulin A deficiency
X-linked agammaglobulinemia
Adenosine deaminase deficiency
Hyper IgM syndrome
Wiskott-Aldrich syndrome
Complement deficiency
Cytomegalovirus infection after transplant (NORD)
Chronic granulomatous disease
Leukocyte adhesion deficiency
DiGeorge syndrome
Glucocorticoids
T-cell development
B-cell development
MHC class I and MHC class II molecules
T-cell activation
B-cell activation, differentiation, and contraction
Cell-mediated immunity of CD4 cells
Cell-mediated immunity of natural killer and CD8 cells
Antibody classes
Contracting the immune response and peripheral tolerance
B- and T-cell memory
Vaccinations
Cytokines
Complement system
Innate immune system
Atrophy, aplasia, and hypoplasia
Hyperplasia and hypertrophy
Metaplasia and dysplasia
Oncogenes and tumor suppressor genes
Endocarditis
Myocarditis
Cardiac tumors
Myocardial infarction
Familial hypercholesterolemia
Hypertriglyceridemia
Cushing syndrome
Hypertension
Pheochromocytoma
Polycystic kidney disease
Renal artery stenosis
Lymphedema
Peripheral artery disease
Nutcracker syndrome
Superior mesenteric artery syndrome
Angiosarcomas
Human herpesvirus 8 (Kaposi sarcoma)
Vascular tumors
Behcet's disease
Kawasaki disease
Deep vein thrombosis
Thrombophlebitis
Adrenal cortical carcinoma
Hyperaldosteronism
Primary adrenal insufficiency
Waterhouse-Friderichsen syndrome
Congenital adrenal hyperplasia
Multiple endocrine neoplasia
Carcinoid syndrome
Neuroblastoma
Zollinger-Ellison syndrome
Hyperprolactinemia
Pituitary adenoma
Prolactinoma
Growth hormone deficiency
Hypopituitarism
Hypoprolactinemia
Diabetes insipidus
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Hyperthyroidism
Thyroid storm
Toxic multinodular goiter
Hashimoto thyroiditis
Hypothyroidism
Postpartum thyroiditis
Thyroid cancer
Adrenal insufficiency: Pathology review
Adrenal masses: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Diabetes insipidus and SIADH: Pathology review
Diabetes mellitus: Pathology review
Hyperthyroidism: Pathology review
Hypopituitarism: Pathology review
Hypothyroidism: Pathology review
Multiple endocrine neoplasia: Pathology review
Parathyroid disorders and calcium imbalance: Pathology review
Pituitary tumors: Pathology review
Thyroid nodules and thyroid cancer: Pathology review
Hyperparathyroidism
Hypoparathyroidism
Biliary colic
Alcohol-associated liver disease
Alpha 1-antitrypsin deficiency
Autoimmune hepatitis
Benign liver tumors
Cirrhosis
Hemochromatosis
Viral hepatitis
Hepatocellular carcinoma
Jaundice
Neonatal hepatitis
Non-alcoholic fatty liver disease
Portal hypertension
Primary biliary cholangitis
Primary sclerosing cholangitis
Reye syndrome
Wilson disease
Acute pancreatitis
Chronic pancreatitis
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Sickle cell disease (NORD)
Folate (Vitamin B9) deficiency
Vitamin B12 deficiency
Alpha-thalassemia
Anemia of chronic disease
Beta-thalassemia
Iron deficiency anemia
Sideroblastic anemia
Aplastic anemia
Mastocytosis (NORD)
Essential thrombocythemia (NORD)
Myelodysplastic syndromes
Myelofibrosis (NORD)
Polycythemia vera (NORD)
Acute leukemia
Chronic leukemia
Hodgkin lymphoma
Non-Hodgkin lymphoma
Disseminated intravascular coagulation
Heparin-induced thrombocytopenia
Von Willebrand disease
Waldenstrom macroglobulinemia
Hemolytic-uremic syndrome
Thrombotic thrombocytopenic purpura
Antithrombin III deficiency
Factor V Leiden
Protein C deficiency
Stevens-Johnson syndrome
Candida
Human herpesvirus 6 (Roseola)
Measles virus
Parvovirus B19
Rubella virus
Varicella zoster virus
Coxsackievirus
Herpes simplex virus
Human papillomavirus
Ankylosing spondylitis
Gout
Rheumatoid arthritis
Septic arthritis
Osteoarthritis
Limited systemic sclerosis (CREST syndrome)
Raynaud phenomenon
Scleroderma
Sjogren syndrome
Pleural effusion
Blood groups and transfusions
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Clot retraction and fibrinolysis
Role of Vitamin K in coagulation
Amino acids and protein folding
Cell cycle
DNA damage and repair
DNA mutations
DNA replication
DNA structure
Epigenetics
Gene regulation
Mitosis and meiosis
Nuclear structure
Nucleotide metabolism
Transcription of DNA
Translation of mRNA
Cell membrane
Cell signaling pathways
Cell-cell junctions
Cellular structure and function
Endocytosis and exocytosis
Nernst equation
Osmosis
Acute intermittent porphyria
Anticoagulants: Direct factor inhibitors
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anti-tumor antibiotics
DNA alkylating medications
Monoclonal antibodies
Ribonucleotide reductase inhibitors
Topoisomerase inhibitors
Blood components
Erythropoietin
Bacillus anthracis (Anthrax)
Bacillus cereus (Food poisoning)
Corynebacterium diphtheriae (Diphtheria)
Listeria monocytogenes
Clostridium botulinum (Botulism)
Clostridium difficile (Pseudomembranous colitis)
Clostridium perfringens
Clostridium tetani (Tetanus)
Actinomyces israelii
Nocardia
Staphylococcus aureus
Staphylococcus epidermidis
Staphylococcus saprophyticus
Streptococcus agalactiae (Group B Strep)
Streptococcus pneumoniae
Streptococcus pyogenes (Group A Strep)
Streptococcus viridans
Enterococcus
Bacteroides fragilis
Bartonella henselae (Cat-scratch disease and Bacillary angiomatosis)
Enterobacter
Escherichia coli
Klebsiella pneumoniae
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Proteus mirabilis
Pseudomonas aeruginosa
Salmonella (non-typhoidal)
Salmonella typhi (typhoid fever)
Serratia marcescens
Shigella
Yersinia enterocolitica
Yersinia pestis (Plague)
Campylobacter jejuni
Helicobacter pylori
Vibrio cholerae (Cholera)
Moraxella catarrhalis
Neisseria gonorrhoeae
Neisseria meningitidis
Bordetella pertussis (Whooping cough)
Brucella
Francisella tularensis (Tularemia)
Haemophilus ducreyi (Chancroid)
Haemophilus influenzae
Pasteurella multocida
Mycobacterium tuberculosis (Tuberculosis)
Mycobacterium avium complex (NORD)
Mycobacterium leprae
Chlamydia pneumoniae
Chlamydia trachomatis
Gardnerella vaginalis (Bacterial vaginosis)
Mycoplasma pneumoniae
Coxiella burnetii (Q fever)
Ehrlichia and Anaplasma
Rickettsia rickettsii (Rocky Mountain spotted fever) and other Rickettsia species
Borrelia burgdorferi (Lyme disease)
Borrelia species (Relapsing fever)
Leptospira
Treponema pallidum (Syphilis)
Adenovirus
Hepatitis B and Hepatitis D virus
Epstein-Barr virus (Infectious mononucleosis)
BK virus (Hemorrhagic cystitis)
JC virus (Progressive multifocal leukoencephalopathy)
Prions (Spongiform encephalopathy)
Norovirus
Hepatitis C virus
West Nile virus
Yellow fever virus
Zika virus
Influenza virus
Human parainfluenza viruses
Mumps virus
Respiratory syncytial virus
Hepatitis A and Hepatitis E virus
Poliovirus
Rhinovirus
Rotavirus
HIV (AIDS)
Rabies virus
PDE5 inhibitors
Protease inhibitors
Cell wall synthesis inhibitors: Cephalosporins
Serotonin and norepinephrine reuptake inhibitors
Cell wall synthesis inhibitors: Penicillins
Monoamine oxidase inhibitors
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Warm autoimmune hemolytic anemia and cold agglutinin (NORD)
Anemia of chronic disease: Year of the Zebra
Myeloproliferative disorders: Pathology review
Leukemias: Pathology review
Coagulation disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Platelet disorders: Pathology review
Plasma cell disorders: Pathology review
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Methemoglobinemia
Pulmonary edema
Pulmonary embolism
Pulmonary shunts
Ventilation
Prerenal azotemia
Postrenal azotemia
Renal azotemia
Hyperkalemia
Hypermagnesemia
Hypercalcemia
Hypernatremia
Hypokalemia
Hyponatremia
Amyloidosis
Vitamin D
Antidiuretic hormone
Sodium homeostasis
Renin-angiotensin-aldosterone system
Parkinson disease
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Thyroid and parathyroid gland histology
Adrenal hormone synthesis inhibitors
Mineralocorticoids and mineralocorticoid antagonists
Hypoglycemics: Insulin secretagogues
Insulins
Miscellaneous hypoglycemics
Cortisol
Synthesis of adrenocortical hormones
Parathyroid hormone
Calcitonin
Phosphate, calcium and magnesium homeostasis
Adrenocorticotropic hormone
Growth hormone and somatostatin
Oxytocin and prolactin
Thyroid hormones
Celiac disease
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Bacterial structure and functions
Herpesvirus medications
Hepatitis medications
Trypanosoma cruzi (Chagas disease)
Plasmodium species (Malaria)

Transcript

Watch video only

Content Reviewers

The name “primary sclerosing cholangitis” or PSC, is actually pretty straightforward, primary refers to it not being known to have been caused by anything else, in other words it isn’t secondary to something else.

Sclerosing means hardening of the tissue and cholangitis is inflammation of the bile ducts.

So with PSC we have this fibrosis and inflammation of both the intra- and extra-hepatic ducts, so inside and outside the liver.

As these cells around the bile ducts become inflamed, die, and harden due to fibrosis, you get this like tightening of the ducts in some areas where there’s been serious fibrosis, and then dilation in other areas that aren’t as affected, and this leads to the classic PSC finding of this sort of “beaded” appearance of the bile ducts.

These areas of fibrosis in the bile ducts can also be seen on histology, and looks a bit like an onion skin since you’ve got these concentric rings of fibrosis around the bile duct, so sometimes it’s referred to as “onion-skin fibrosis”.

Again, with PSC, we don’t really know what causes it right? One clue though is that it’s been known to be associated with ulcerative colitis which is an autoimmune disease and crohn’s disease which is immune-system related; knowing that, PSC’s thought to possibly be an autoimmune disorder itself involving the immune system’s T cells attacking and destroying bile duct epithelial cells.

Why they might start doing this, though, is not very well known, and likely happens in people with certain genetic predispositions when they’re exposed to some specific stimuli in their environment.

Certain genetic factors have been linked to developing PSC; studies have shown that patients with PSC tend to have in common specific human leukocyte antigens, or HLAs.

HLAs are these specific markers on cells that tell your body whether these cells are your own cells or someone else’s cells, and sometimes, for reasons that are usually not well known, the body’s immune system might think that certain HLAs or cell surface markers are foreign even when they’re your own, leading to an autoimmune disorder.

Specific HLA’s that have been common among people with PSC are HLA-B8, HLA-DR3, and HLA-DRw52a.

Another piece of supporting evidence for the autoimmune theory is that most patients with PSC have elevated IgM antibody levels in the serum, as well as an antibody called p-ANCA.

P-ANCA stands for perinuclear anti-neutrophil cytoplasmic antibody, so this is a specific antibody that targets antigens in the cytoplasm or nucleus of neutrophils, the perinuclear part means that the antibody targets an antigen around the nucleus.

Here’s an immunofluorescent image of p-ANCAs, the antibodies in this image are shown in orange, and notice they’ve sort of aggregated around the nucleus, meaning that they bind to an antigen around the nucleus.

A very high proportion, as high as 80%, of patients with PSC have this p-ANCA staining pattern.

Symptoms of PSC are similar to the symptoms of obstructive jaundice, since these “beads” or pinched areas are obstructing the flow of bile.

Also, as these epithelial cells lining the ducts die off, bile can now be allowed to leak out past the cells into the interstitial space, where it can access the bloodstream.

Key Takeaways

Primary sclerosing cholangitis (PSC) is a disease of the bile ducts that causes inflammation and obliterative fibrosis of bile ducts inside and/or outside of the liver. This results in scarring of the biliary tree, which impedes the flow of bile to the intestines and can ultimately lead to cirrhosis of the liver, liver failure, and liver cancer. Symptoms of PSC can include fatigue, itching, jaundice, abdominal pain, and weight loss. If left untreated, PSC can lead to liver failure. Definitive treatment is liver transplant, but ursodeoxycholic acid (UDCA help to slow disease progression and alleviate symptoms.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw Hill Professional (2019)
  5. "Primary Sclerosing Cholangitis" New England Journal of Medicine (2016)
  6. "The dynamic biliary epithelia: Molecules, pathways, and disease" Journal of Hepatology (2013)
  7. "Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis" Annals of Hepatology (2014)